NSCLC tissues; matched adjacent normal tissues; tumor tissues; xenograft tumor tissues; lung tissues
CALU3; CALU6; A549; H1229; H1299; HBE
cell line-derived xenograft
proliferation (inhibits); migration (inhibits); invasion (inhibits); metastasis (inhibits); glycolysis (inhibits); apoptosis (promotes); ceRNA regulation (promotes)
Actinomycin D / DRB Stability Assay; RNase R Treatment; FISH / smFISH; RT-qPCR; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Transwell Assay; TUNEL; IHC (Immunohistochemistry); Western Blot; In Vivo Animal Model; H&E Staining; Survival Analysis; Bioinformatics Analysis
Low circ_0008797 expression is associated with poor 60-month overall survival in NSCLC patients; circ_0008797 might be a promising target for NSCLC treatment.
circ_0008797 is down-regulated in NSCLC tissues and cell lines, and higher expression is associated with better overall survival. Functionally, circ_0008797 suppresses proliferation, migration, invasion, glycolysis, tumor growth and metastasis while promoting apoptosis. Mechanistically, it acts as a cytoplasmic miR-301a-3p sponge to increase SOCS2 expression.
0.8712
circ_0008797 attenuates non-small cell lung cancer proliferation, metastasis, and aerobic glycolysis by sponging miR-301a-3p/SOCS2.
combined biological and clinical study